Related Experiment Video

Updated: Apr 26, 2026

Seven Steps to Stellate Cells
06:40

Seven Steps to Stellate Cells

Published on: May 10, 2011

33.7K

Myocardin related transcription factor A programs epigenetic activation of hepatic stellate cells

Wenfang Tian1, Chenzhi Hao1, Zhiwen Fan1

  • 1State Key Laboratory of Reproductive Medicine, Department of Pathophysiology, Key Laboratory of Cardiovascular Disease, Nanjing Medical University, Nanjing, Jiangsu, China.

Journal of Hepatology
|August 12, 2014
PubMed

Insights

Myocardin related transcription factor A (MRTF-A) drives hepatic stellate cell activation and liver fibrosis by recruiting COMPASS to fibrogenic gene promoters. Blocking MRTF-A or COMPASS inhibits fibrosis, offering new therapeutic targets for liver disease.

Area of Science:

  • Epigenetics
  • Liver Pathophysiology
  • Cell Biology

Background:

  • Hepatic stellate cell (HSC) activation is central to liver injury and cirrhosis.
  • The role of epigenetic machinery in HSC activation remains incompletely understood.
  • Myocardin related transcription factor A (MRTF-A) is investigated for its role in HSC activation.

Purpose of the Study:

  • To elucidate the function of MRTF-A in hepatic stellate cell activation.
  • To investigate the epigenetic mechanisms underlying liver fibrosis.
  • To identify potential therapeutic targets for liver disease.

Main Methods:

  • Induction of liver fibrosis in wild type and MRTF-A deficient mice.
  • Quantitative analysis of gene and protein expression (real-time PCR, Western blotting, immunohistochemistry).
  • Chromatin immunoprecipitation (ChIP) assays to assess protein-DNA binding and histone modifications.
  • Lentiviral-mediated knockdown using siRNA and shRNA.

Main Results:

  • MRTF-A deficient mice showed resistance to liver fibrosis.
  • Suppression of activated HSC signature genes in the absence of MRTF-A.
  • MRTF-A deficiency erased key histone modifications (H3K4 di- and tri-methylation) at fibrogenic gene promoters.
  • MRTF-A recruits the COMPASS complex to activate fibrogenic genes; COMPASS component silencing blocked fibrosis.
  • Oestradiol inhibited HSC activation by reducing COMPASS expression and binding.

Conclusions:

  • A novel mechanism linking MRTF-A-dependent histone H3K4 methylation to HSC activation is identified.
  • MRTF-A and the COMPASS complex are critical regulators of fibrogenic gene transcription in HSCs.
  • These findings highlight potential therapeutic strategies for liver fibrosis targeting the MRTF-A/COMPASS pathway.
Abstract

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.1K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.0K
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.1K
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
29
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.9K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.0K